Peter Scacheri
Affiliations: | 1999 | Biochemistry | University of Pittsburgh, Pittsburgh, PA, United States |
Google:
"Peter Scacheri"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fernandez-Rozadilla C, Timofeeva M, Chen Z, et al. (2022) Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. Nature Genetics |
| Corradin O, Sallari R, Hoang AT, et al. (2022) Convergence of case-specific epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdose. Molecular Psychiatry |
| Factor DC, Barbeau AM, Allan KC, et al. (2020) Cell Type-Specific Intralocus Interactions Reveal Oligodendrocyte Mechanisms in MS. Cell |
| Shang S, Yang J, Jazaeri AA, et al. (2019) Chemotherapy-induced distal enhancers drive transcriptional program to maintain the chemoresistant state in ovarian cancer. Cancer Research |
| Mack SC, Singh I, Wang X, et al. (2019) Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma. The Journal of Experimental Medicine |
| Bien SA, Su YR, Conti DV, et al. (2019) Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer. Human Genetics |
| Karnuta JM, Scacheri PC. (2019) Enhancers: bridging the gap between gene control and human disease. Human Molecular Genetics. 27: R219-R227 |
| Patten DK, Corleone G, Győrffy B, et al. (2018) Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer. Nature Medicine |
| Bailey SD, Zhang X, Desai K, et al. (2018) Publisher Correction: ZNF143 provides sequence specificity to secure chromatin interactions at gene promoters. Nature Communications. 9: 16194 |
| Morrow JJ, Bayles I, Funnell APW, et al. (2018) Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. Nature Medicine |